Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bernstein

Showing results (201-210 of 300) with videos related to

Pageof 30
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group StudyLisa R Bomgaars, Mark Bernstein, Mark Krailo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 13, 2009
Launching invasive, first-in-human trials against Parkinson's disease: ethical considerationsJonathan Kimmelman, Alex John London, Bernard Ravina, et al.
Pediatric Blood & Cancer|July 30, 2013
A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortiumAlexandra P Zorzi, Mark Bernstein, Yvan Samson, et al.
Frontiers in Oncology|May 6, 2022
Benzodiazepine Sedation and Postoperative Neurological Deficits after Awake Craniotomy for Brain Tumor - An Exploratory Retrospective Cohort StudyEric Plitman, Tumul Chowdhury, Gabriel Paquin-Lanthier, et al.
Journal of Neurosurgical Anesthesiology|August 19, 2021
Risk Factors and Characteristics of Intraoperative Seizures During Awake Craniotomy: A Retrospective Cohort Study of 562 Consecutive Patients With a Space-occupying Brain LesionGabriel Paquin-Lanthier, Sudhakar Subramaniam, Kok Weng Leong, et al.
BMC Health Services Research|November 17, 2007
Adoption of an innovation to repair aortic aneurysms at a Canadian hospital: a qualitative case study and evaluationNathalie M Danjoux, Douglas K Martin, Pascale N Lehoux, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 24, 2015
Serum lactate as a potential biomarker of non-glial brain tumorsSuparna Bharadwaj, Lashmi Venkatraghavan, Ramamani Mariappan, et al.
Journal of Emergency Management (Weston, Mass.)|May 23, 2020
A multiple casualty incident clinical tracking form for civilian hospitalsSpiros G Frangos, Marko Bukur, Cherisse Berry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Phase I trial and pharmacokinetic study of raltitrexed in children with recurrent or refractory leukemia: a pediatric oncology group studyTerzah M Horton, Susan M Blaney, Anne-Marie Langevin, et al.
Pediatric Blood & Cancer|July 5, 2007
A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: a Children's Oncology Group studyAnne-Marie Langevin, Mark Bernstein, John G Kuhn, et al.
Pageof 30

Showing results (201-210 of 300) with videos related to

Sort By:
Pageof 30
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group StudyLisa R Bomgaars, Mark Bernstein, Mark Krailo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 13, 2009
Launching invasive, first-in-human trials against Parkinson's disease: ethical considerationsJonathan Kimmelman, Alex John London, Bernard Ravina, et al.
Pediatric Blood & Cancer|July 30, 2013
A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortiumAlexandra P Zorzi, Mark Bernstein, Yvan Samson, et al.
Frontiers in Oncology|May 6, 2022
Benzodiazepine Sedation and Postoperative Neurological Deficits after Awake Craniotomy for Brain Tumor - An Exploratory Retrospective Cohort StudyEric Plitman, Tumul Chowdhury, Gabriel Paquin-Lanthier, et al.
Journal of Neurosurgical Anesthesiology|August 19, 2021
Risk Factors and Characteristics of Intraoperative Seizures During Awake Craniotomy: A Retrospective Cohort Study of 562 Consecutive Patients With a Space-occupying Brain LesionGabriel Paquin-Lanthier, Sudhakar Subramaniam, Kok Weng Leong, et al.
BMC Health Services Research|November 17, 2007
Adoption of an innovation to repair aortic aneurysms at a Canadian hospital: a qualitative case study and evaluationNathalie M Danjoux, Douglas K Martin, Pascale N Lehoux, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 24, 2015
Serum lactate as a potential biomarker of non-glial brain tumorsSuparna Bharadwaj, Lashmi Venkatraghavan, Ramamani Mariappan, et al.
Journal of Emergency Management (Weston, Mass.)|May 23, 2020
A multiple casualty incident clinical tracking form for civilian hospitalsSpiros G Frangos, Marko Bukur, Cherisse Berry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Phase I trial and pharmacokinetic study of raltitrexed in children with recurrent or refractory leukemia: a pediatric oncology group studyTerzah M Horton, Susan M Blaney, Anne-Marie Langevin, et al.
Pediatric Blood & Cancer|July 5, 2007
A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: a Children's Oncology Group studyAnne-Marie Langevin, Mark Bernstein, John G Kuhn, et al.
Pageof 30